AzTrials
AzTrials

Femoral Neck FracturesNCT07780006

Efficacy of Oral Nutritional Supplement in Femoral Neck Fracture Patients Undergoing Hip Arthroplasty

A study testing Oral nutritional supplementation in people with Femoral Neck Fractures and Geriatric Hip Fracture, run by Thammasat University at 1 site in Thailand.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

This study aim to compare the efficacy of oral nutritional supplementation (ONS) in femoral neck fracture patients undergoing hip arthroplasty compared with placebo. The hypothesis is "Oral nutritional supplement with Beta-hydroxy-beta-methylbutyrate (HMB) can improve muscle strength in femoral neck fracture patients… Read more about this study

Who is it for?
Ages 65 years and older
What is being tested?
Oral nutritional supplementation
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteThailand
Study dates
Oct 2026to Dec 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Femoral neck fracture patients undergoing hip arthroplasty (Total hip arthroplasty or bipolar hemiarthroplasty)
  • Age ≥ 65 years
  • American Society of Anesthesiologists (ASA) class I-III
  • Participants understand and consent to the protocol of the trial

Who cannot join

  • Pathologic fracture or high impact fracture
  • Morbid obesity (Body mass index > 40)
  • Chronic kidney disease (Chronic kidney disease stage > 3b or estimated glomerular filtration rate (eGFR) < 30)
  • Thyroid disease or endrocrinopathy
  • Gastrointestinal intolerance preventing oral supplementation or Malabsorption syndromes
  • Malignancy with radiotherapy or chemotherapy
Show all 9Show fewer
  • Cognitive disorder
  • Decompensated Liver Disease or Cirrhosis Child-Pugh Class B-C
  • Known allergy/intolerance to milk or other supplement ingredients

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Natthasit Wongwarawanith, MD contact

+66868855682

natthasit_fight@hotmail.com

Supakit Kanitnate, MD contact

+66899853635

naypeng@hotmail.com

Thailand1 site
  • Thammasat University

    Pathum Thani, 12120

    Department of Orthopaedics, Thammasat University, +669269775, orthotunited@orthothamma.com

Other trials in Thailand

About this study

Official title: Efficacy of Oral Nutritional Supplement in Femoral Neck Fracture Patients Undergoing Hip Arthroplasty: A Randomized Controlled Trial

This study aim to compare the efficacy of oral nutritional supplementation (ONS) in femoral neck fracture patients undergoing hip arthroplasty compared with placebo. The hypothesis is "Oral nutritional supplement with Beta-hydroxy-beta-methylbutyrate (HMB) can improve muscle strength in femoral neck fracture patients undergoing hip arthroplasty".

Femoral neck fracture patients aged more than 65 years will be enrolled and allocated into 2 groups

Read more
  • ONS group: Oral nutritional supplement (Ensure® Plus Advance) 2 serves / day x 30 days + Standard oral intake
  • Control group: Standard oral intake

Primary outcome is Grip strength, assessed using hand dynamometer on admission and 2, 6, 12 weeks postoperatively.

Secondary outcomes are

  • Serum albumin assessed on admission and 2, 6, 12 weeks postoperatively
  • Barthel index assessed at 2, 6, 12 weeks postoperatively
  • Mini Nutritional Assessment (MNA), Geriatric Nutritional Risk Index (GNRI) assessed at 2, 6, 12 weeks postoperatively
  • Length of stay (day)
  • Time up and go (TUG), assessed at 2, 6, 12 weeks postoperatively
  • Oxford hip score (OHS), assessed at 2, 6, 12 weeks postoperatively
  • Complications, rate of readmission, mortality rate assessed until 3 months
Being tested
Oral nutritional supplementation
Keywords
Femoral neck fractures, Oral nutritional supplementation, HMB
Medical subject headings
Femoral Neck Fractures, Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oral nutritional supplementationDietary supplement

    Also called Ensure Advanced Plus

    Oral nutritional supplement that consists of 20 grams of protein, 1.5 grams of calcium β-hydroxy-β-methylbutyrate (CaHMB), 0.5 gram of calcium, 500 international units (IU) of vitamin D and calories of 330 kcal per one bottle of 220 ml (Ensure® Advance Plus, Abbott Laboratorios S.A.)

Study groups in NCT07780006
Study groupRoleWhat they receive
ONS groupExperimentalReceive oral nutritional supplement (Ensure® Plus Advance) 2 serves / day x 30 days + Standard oral intake
Receives: Dietary Supplement: Oral nutritional supplementation
Control groupNo interventionReceive standard oral intake

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hand grip strength

    Hand grip strength, assess using hand dynamometer

    Measured: 12 weeks postoperatively

Secondary outcomes (9)
  1. Hand grip strength

    Hand grip strength, assess using hand dynamometer

    Measured: 2, 6 weeks postoperatively

  2. Body weight

    Measured: 2, 6, 12 weeks postoperatively

  3. Body mass index (BMI)

    Measured: 2, 6, 12 weeks postoperatively

  4. Serum albumin

    Measured: 2, 6, 12 weeks postoperatively

  5. Time up and go (TUG)

    Performance-based outcome

    Measured: 2, 6, 12 weeks postoperatively

  6. Oxford hip score (OHS)

    Patient-reported outcomes measurement of the hip function. Scores range from 0 to 48. Higher scores mean greater hip function and less pain.

    Measured: 2, 6, 12 weeks postoperatively

  7. Barthel index

    Index for Activities of Daily Living. Scores range from 0 to 100, with higher scores mean the person is more independent.

    Measured: 2, 6, 12 weeks postoperatively

  8. Mini Nutritional Assessment (MNA)

    Validated tool for assessment of elderly nutritional status. Scores range from 0 to 30. The higher scores mean normal nutritional status of the participants.

    Measured: 2, 6, 12 weeks postoperatively

  9. Geriatric Nutritional Risk Index (GNRI)

    A tool used to evaluate nutritional risk, morbidity, and mortality in older adults. Scores are calculated from serum albumin and body weight of the participants (No range). Higher scores means low risk of malnutrition.

    Measured: 2, 6, 12 weeks postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionOct 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07780006
Sponsor's protocol ID
Ensure_Plus
Status last verified
Aug 2026
First submitted
14 Aug 2026
Last updated
21 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ekinci O, Yanik S, Terzioglu Bebitoglu B, Yilmaz Akyuz E, Dokuyucu A, Erdem S. Effect of Calcium beta-Hydroxy-beta-Methylbutyrate (CaHMB), Vitamin D, and Protein Supplementation on Postoperative Immobilization in Malnourished Older Adult Patients With Hip Fracture: A Randomized Controlled Study. Nutr Clin Pract. 2016 Dec;31(6):829-835. doi: 10.1177/0884533616629628. Epub 2016 Jul 9.

    PubMed 26965178
  • Ashkenazi I, Rotman D, Amzalleg N, Graif N, Amal Khoury, Ben-Tov T, Steinberg E. Efficacy of Oral Nutritional Supplements in Patients Undergoing Surgical Intervention for Hip Fracture. Geriatr Orthop Surg Rehabil. 2022 May 20;13:21514593221102252. doi: 10.1177/21514593221102252. eCollection 2022.

    PubMed 35615598
  • Malafarina V, Uriz-Otano F, Malafarina C, Martinez JA, Zulet MA. Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients. A multi-centre randomized trial. Maturitas. 2017 Jul;101:42-50. doi: 10.1016/j.maturitas.2017.04.010. Epub 2017 Apr 22.

    PubMed 28539168
  • Lin Z, Zhao A, He J. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on the Muscle Strength in the Elderly Population: A Meta-Analysis. Front Nutr. 2022 Jul 13;9:914866. doi: 10.3389/fnut.2022.914866. eCollection 2022.

    PubMed 35911112
  • Holecek M. Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions. J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):529-541. doi: 10.1002/jcsm.12208. Epub 2017 May 10.

    PubMed 28493406
  • Kuriyan R, Lokesh DP, Selvam S, Jayakumar J, Philip MG, Shreeram S, Kurpad AV. The relationship of endogenous plasma concentrations of beta-Hydroxy beta-Methyl Butyrate (HMB) to age and total appendicular lean mass in humans. Exp Gerontol. 2016 Aug;81:13-8. doi: 10.1016/j.exger.2016.04.013. Epub 2016 Apr 20.

    PubMed 27108182
  • Wu H, Xia Y, Jiang J, Du H, Guo X, Liu X, Li C, Huang G, Niu K. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2015 Sep-Oct;61(2):168-75. doi: 10.1016/j.archger.2015.06.020. Epub 2015 Jul 3.

    PubMed 26169182
  • Berton L, Bano G, Carraro S, Veronese N, Pizzato S, Bolzetta F, De Rui M, Valmorbida E, De Ronch I, Perissinotto E, Coin A, Manzato E, Sergi G. Effect of Oral Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation on Physical Performance in Healthy Old Women Over 65 Years: An Open Label Randomized Controlled Trial. PLoS One. 2015 Nov 3;10(11):e0141757. doi: 10.1371/journal.pone.0141757. eCollection 2015.

    PubMed 26529601
  • Fitschen PJ, Wilson GJ, Wilson JM, Wilund KR. Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in elderly and clinical populations. Nutrition. 2013 Jan;29(1):29-36. doi: 10.1016/j.nut.2012.05.005. Epub 2012 Oct 22.

    PubMed 23085015
  • Rizzoli R, Stevenson JC, Bauer JM, van Loon LJ, Walrand S, Kanis JA, Cooper C, Brandi ML, Diez-Perez A, Reginster JY; ESCEO Task Force. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2014 Sep;79(1):122-32. doi: 10.1016/j.maturitas.2014.07.005. Epub 2014 Jul 17.

    PubMed 25082206
  • Avenell A, Smith TO, Curtain JP, Mak JC, Myint PK. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev. 2016 Nov 30;11(11):CD001880. doi: 10.1002/14651858.CD001880.pub6.

    PubMed 27898998
  • Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Hooper L, Kiesswetter E, Maggio M, Raynaud-Simon A, Sieber C, Sobotka L, van Asselt D, Wirth R, Bischoff SC. ESPEN practical guideline: Clinical nutrition and hydration in geriatrics. Clin Nutr. 2022 Apr;41(4):958-989. doi: 10.1016/j.clnu.2022.01.024. Epub 2022 Mar 5.

    PubMed 35306388
  • Miyanishi K, Jingushi S, Torisu T. Mortality after hip fracture in Japan: the role of nutritional status. J Orthop Surg (Hong Kong). 2010 Dec;18(3):265-70. doi: 10.1177/230949901001800301.

    PubMed 21187532
  • Uriz-Otano F, Pla-Vidal J, Tiberio-Lopez G, Malafarina V. Factors associated to institutionalization and mortality over three years, in elderly people with a hip fracture-An observational study. Maturitas. 2016 Jul;89:9-15. doi: 10.1016/j.maturitas.2016.04.005. Epub 2016 Apr 8.

    PubMed 27180154
  • Huang H, Liu Y, Zhang BF. Elevated albumin: a protective factor against mortality in geriatric hip fracture patients. J Orthop Surg Res. 2025 May 19;20(1):485. doi: 10.1186/s13018-025-05873-2.

    PubMed 40390133

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in